Hot Features
Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 d... Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based in Fort Lauderdale, Florida. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.64 | -21.4046822742 | 2.99 | 3.0396 | 2.28 | 20868 | 2.66747223 | CS |
| 4 | -0.29 | -10.9848484848 | 2.64 | 3.09 | 2.28 | 18286 | 2.65708211 | CS |
| 12 | -0.87 | -27.0186335404 | 3.22 | 3.465 | 2.28 | 16262 | 2.80591563 | CS |
| 26 | -1.03 | -30.4733727811 | 3.38 | 4.5 | 2.28 | 23995 | 3.24410719 | CS |
| 52 | -0.35 | -12.962962963 | 2.7 | 6.2 | 1.67 | 156393 | 3.45229145 | CS |
| 156 | 1.84 | 360.784313725 | 0.51 | 6.2 | 0.044 | 927573 | 0.45706286 | CS |
| 260 | 1.484 | 171.362586605 | 0.866 | 6.2 | 0.044 | 1322004 | 0.86431922 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.